Haleon (HLN) Stock Forecast & Price Target

$9.94 +0.17 (+1.69%)

Closing price 07/27/2026 03:59 PM Eastern

Extended Trading

$9.94 0.00 (0.00%)

As of 07/27/2026 07:34 PM Eastern

Compare

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 10 Analyst Ratings

Sell
2

Hold
3

Buy
5

Based on 10 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 2 have given a sell rating, 3 have given a hold rating, 3 have given a buy rating, and 2 have given a strong buy rating for HLN.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

Type	Current Forecast 7/28/25 to 7/28/26	1 Month Ago 6/28/25 to 6/28/26	3 Months Ago 4/29/25 to 4/29/26	1 Year Ago 7/28/24 to 7/28/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	4 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	$12.33	$12.33
Forecasted Upside	N/A	N/A	32.31% Upside	27.06% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Haleon Stock vs. The Competition

Type	Haleon	Medical Companies	Broader Market
Consensus Rating Score	2.50	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	N/A	959.53% Upside	13.33% Upside
News Sentiment Rating	Neutral News See Recent HLN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/21/2026	Zacks Research Not Rated		Downgrade	Hold ➝ Strong Sell
6/30/2026	Weiss Ratings 5 of 5 stars		Reiterated Rating	Hold (C)
6/16/2026	Rothschild & Co Redburn 4 of 5 stars		Downgrade	Strong-Buy ➝ Hold
4/30/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell
3/17/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
1/21/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
1/20/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
12/15/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Overweight
9/16/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Warren Ackerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight
9/10/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Buy
Get the Latest News and Ratings for HLN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.
5/27/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Neutral ➝ Outperform	$13.40	+20.07%
1/8/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C. Elliott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
10/1/2024	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	G. Delmas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/6/2024	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	B. Davies Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:47 AM ET.

Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 27, 2026. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

Here are some ways that investors could benefit from investing in Haleon plc:

The current stock price is around $10.10, which may present a buying opportunity for investors looking for growth in the consumer healthcare sector.
Haleon plc has a market capitalization of approximately $44.46 billion, indicating a strong presence in the market and potential for stability and growth.
The company has received a consensus rating of "Moderate Buy" from analysts, suggesting positive sentiment and potential for price appreciation.
Recent institutional investments, including significant stakes from various financial firms, reflect confidence in Haleon plc's future performance.
Haleon plc offers a diverse product portfolio, including over-the-counter medicines and health supplements, catering to a broad consumer base and enhancing revenue potential.

Haleon
Bear Case

Investors should be bearish about investing in Haleon plc for these reasons:

The company has a relatively high P/E ratio of 25.88, which may indicate that the stock is overvalued compared to its earnings, potentially leading to price corrections.
Haleon plc's beta of 0.13 suggests lower volatility compared to the market, which may limit potential gains during bullish market conditions.
Despite recent growth, the company has a quick ratio of 0.71, indicating potential liquidity concerns that could affect its ability to meet short-term obligations.
With only 6.67% of the stock owned by institutional investors and hedge funds, there may be less market support during downturns.
The company has a debt-to-equity ratio of 0.47, which, while manageable, indicates some reliance on debt financing that could pose risks in a rising interest rate environment.

HLN Forecast - Frequently Asked Questions

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 2 sell ratings, 3 hold ratings, 3 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HLN shares.

According to analysts, Haleon's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Haleon's stock had 2 downgrades by analysts.

Haleon has been rated by research analysts at Deutsche Bank Aktiengesellschaft, Rothschild & Co Redburn, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Haleon more than other "medical" companies. The consensus rating for Haleon is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how HLN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

This page (NYSE:HLN) was last updated on 7/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Haleon (HLN) Stock Forecast & Price Target

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

HLN Analyst Ratings Over Time

HLN Analyst Recommendations By Month

HLN Price Targets by Month

Haleon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Haleon
Bull Case

Haleon
Bear Case

HLN Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Haleon (HLN) Stock Forecast & Price Target

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

HLN Analyst Ratings Over Time

HLN Analyst Recommendations By Month

HLN Price Targets by Month

Haleon Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Haleon Bull Case

Haleon Bear Case

HLN Forecast - Frequently Asked Questions

Should I buy or sell Haleon stock right now?

Does Haleon's stock price have much downside?

Has Haleon been downgraded by Wall Street analysts recently?

What analysts cover Haleon?

Do Wall Street analysts like Haleon more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Haleon
Bull Case

Haleon
Bear Case